GlaucoNova Labs Logo

GlaucoNova Labs

Smart Eyewear Revolutionizing Glaucoma Management

Request a Demo
94.7%
Accuracy
24/7
Monitoring
$200
Cost
GlaucoNova Labs Logo

Revolutionary Eye Care

Ultrasound-Infused eyeglasses for monitoring eye pressure in glaucoma patients continuously at low costs.

The Problem

Problem Framing:

Glaucoma affects 80 million individuals worldwide with a global economic burden of $411 billion. The foremost biomarker is elevated intraocular pressure (IOP), the buildup of aqueous humor damaging optic nerves. Causes underlying this phenomenon are unknown, there exists no cure, and it typically lacks warning symptoms, leading to gradual and "silent" vision loss.

Problem Framing Illustration
Current Treatments Illustration

Current Treatments:

Eyedrops are a pervasive treatment to reduce IOP, but their effectiveness is limited by the inability to predict when patients will experience IOP spikes, which can spike 110% beyond normal levels in a matter of seconds at any time of day without one's awareness. This is why 20% of patients become completely blind in at least one eye in 15 years of follow-up.

The Need for Frequent Monitoring:

Despite the need for frequent monitoring, current tonometers are invasive (direct contact with the cornea), non-portable (only found in clinics), and expensive (priced above $1240). They provide a limited snapshot of IOP fluctuations and lead to prescribing ineffective and non-personalized treatment.

Who Are We?

Our Team

Soham Chakraborty

Soham Chakraborty

Founder/CEO

Soham has extensive BioE research and familial experience with ocular diseases. Experimentation, Product, and Growth Strategy.

Jeffery Zhang

Jeffery Zhang

CTO

Jeffrey is knowledgable about PCB Design and Software. Software Development, Prototype Design, and Engineering.

Our Technology

Our innovation, GlaucoSolve Glasses is a non-invasive, wearable, cost-effective, and remote monitoring solution that uses ultrasound transducers, receivers, and Arduino modules to monitor IOP. By applying acoustic force to the cornea and analyzing the reflected signal, we can compute various ultrasound parameters and correlate them to get the patient's eye pressure. Realtime data will be sent to a mobile app allowing physicians to monitor long-term glaucoma progression remotely and alerting patients on when they should apply eye drops, mitigating optic nerve damage. Moreover, we plan to develop a model with collected data, offering AI insights into glaucoma diagnosis. By learning nuanced IOP patterns in patients with all stages of glaucoma, it allows our model to help ophthalmologists spot signs of glaucoma and predict patients' future IOP trajectory to evaluate the effectiveness of treatments just days after prescription.

Our Prototypes

3D Prototype Model

3D Prototype Model

Physical Prototype

Physical Prototype

Technology Schematic

Technology Schematic

Mobile App

Mobile App Interface

Our Unique Value

So what separates GlaucoSolve from the rest of the IOP monitors? We hold the first wearable technology design capable of continuous IOP monitoring, with a significantly cheaper price point and remote physician monitoring feature. As you can see in the comparison table below, our product outshines each alternative IOP monitor in multiple key factors and is over five times cheaper than the current cheapest option.

Comparison Table

The Science Behind GlaucoGlasses

Figure 1: Scientific concept of our technology

Widely used in elasticity imaging, acoustic radiation force from ultrasound waves induces physical deformation in tissues- elucidating data about the elasticity of the tissue. Applying a known magnitude of acoustic force to the cornea of the eye will similarly enable the measurement of corneal deformation, as shown in Figure 1, offering insights into elasticity, which is known to be correlated to IOP (Lee et al., 2021).

Four variables will be experimentally extracted from the reflected ultrasound signal, which will correlate to IOP. These four parameters are corneal deformation, flight time, amplitude, and acoustic impedance.

Corneal Deformation

The proposed technique to enable the calculation of the final corneal deformation (δ), which is the amount the cornea displaces from its initial position as a result of acoustic radiation force, is the fact that it is the absolute difference between the deformation due to acoustic radiation force and deformation due to IOP. For the average human eye, δ = 38999.76ARFPIOPT - 1116.06, where ARFP is the pressure from acoustic radiation force & IOPT is the true IOP in Pascals (Lee et al., 2021). Thus, corneal deformation should be inversely proportional to IOP, such that higher IOP is correlated with lower corneal deformation, and vice-versa.

Time of Flight

The reflected ultrasound beam from the cornea has two paths: one under normal conditions (black beam in Figure 1) and another during corneal deformation (red beam in Figure 1). Due to the longer distance traveled by the red ultrasound beam, it is expected that the time of flight will be higher during corneal deformation- inversely correlating to IOP (Zhang et al., 2017).

Amplitude

When ultrasonic waves traverse through the air, energy losses, known as attenuation, occur due to scattering, absorption, and density differences at material interfaces. Greater corneal deformation results in longer wave travel, increased acoustic force loss to air, and diminished amplitude, which is the maximum magnitude of received signals, which is expected to be proportional to IOP (Zhang et al., 2017).

Acoustic Impedance

Acoustic Impedance is the resistance against ultrasound wave propagation through tissue, which results from the density of tissue and increases with higher IOP. It is calculated using the equation A1A0 = Z1 - Z0Z1 + Z0, where A0 = a known constant amplitude of signal emitted, A0 = amplitude of signal received, Z0 = acoustic impedance of aqueous humor inside the eye ≈ 1.48 MPa, and Z1 = acoustic impedance of the cornea (Zhang et al., 2017).

Experimental Results

Experimental Setup

After engineering an Arduino-based prototype, experimentation was conducted using the apparatus shown in the image on the right. Since models of the human eye are expensive, the prototype was tested on gelatin phantoms made of gelatin powder and water- an accurate model of biological tissues often used for ultrasound imaging studies. Seven gelatin phantoms, each containing 70 mL of water, with varying gelatin concentrations (10%, 15%, 20%, 25%, 30%, 35%, and 40%) were created to simulate different IOP values of the eye and the ultrasound time of flight and amplitude were extracted for each model. They were then statistically correlated using a linear regression model to the true IOP, which was measured using the iCARE IC100 tonometer, pervasively used in clinics. The results were splendid, yielding a 92% accuracy of IOP correlation with a mean absolute error of solely 5 mmHg. The research paper preprint documenting experimental results is ready to be submitted to Frontiers publication, and the design patent is in the second stage of filing.

Experimental Setup
Figure 2: Correlation between corneal displacement and true IOP

Figure 2: Correlation between corneal displacement and true IOP. Deformation under ultrasound is inversely proportional to IOP with 75.36% correlation.

Figure 3: Correlation between ultrasound amplitude and true IOP

Figure 3: Correlation between ultrasound amplitude and true IOP. Amplitude, the maximum ultrasound signal reflected, is proportional to IOP with 92.06% correlation.

Figure 4: Correlation between time of ultrasound flight in air and true IOP

Figure 4: Correlation between time of ultrasound flight in air and true IOP. The time of flight is inversely proportional to IOP, with an 82.2% correlation.

Testimonies

"This product would be very beneficial and useable from the comfort of one's home, reduce the need of going to an eye doctor in person."

Dr. Sewa Ram Singal

General physician at Humber River Hospital and Trillium Health Partners Credit Valley Hospital

"It is a great thinking in this direction as glaucoma is actually a blinding disease."

Dr. Shaffie Baidwal Gupta

Ophthalmologist at Fortis Hospital

References

Baker, L., Mansouri, K., Quigley, H. A., & Sit, A. J. (2016). Update on 24-Hour IOP Monitoring. American Academy of Ophthalmology. https://www.aao.org/eyenet/article/update-on-24-hour-iop-monitoring

Enabnit, A. (2023, July 10). Applanation Tonometry: Procedure and Uses. DoveMed. Retrieved January 29, 2024, from https://www.dovemed.com/health-topics/focused-health-topics/applanation-tonometry-procedure-and-uses

Farhood, Q. K. (2012, December 27). Comparative evaluation of intraocular pressure with an air-puff tonometer versus a Goldmann applanation tonometer. NIH. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534293/

Goel, M. (2010, September 3). Aqueous Humor Dynamics: A Review - PMC. NCBI. Retrieved January 30, 2024, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3032230/

Hg, I., Hashimoto, M., & Hung, J.-H. (2021, November 4). Description. EyeKnow. Retrieved December 13, 2023, from https://2020.igem.org/Team:NCKU_Tainan/Description

Jonas, J. B. (2018, May 17). Intraocular pressure and its normal range adjusted for ocular and systemic parameters. The Beijing Eye Study 2011. NCBI. Retrieved January 30, 2024, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5957383/

Kalayoglu, M. V. (2007, November 20). 180 Years of Evolution of the Tonometer. OphthalmologyWeb. Retrieved January 29, 2024, from https://www.ophthalmologyweb.com/Tech-Spotlights/26468-180-Years-of-Evolution-of-the-Tonometer/

Kaleem, M. (n.d.). Glaucoma. Johns Hopkins Medicine. https://www.hopkinsmedicine.org/health/conditions-and-diseases/glaucoma

Kendall, J., & Faragher, J. (2007, October 10). Ultrasound-guided central venous access: A homemade phantom for simulation. ResearchGate. https://www.researchgate.net/publication/5909055_Ultrasound-guided_central_venous_access_A_homemade_phantom_for_simulation

Lee, H., Jeong, E., Sung, J., Choi, B., & Jeong, J. (2021, March 7). An Intraocular Pressure Measurement Technique Based on Acoustic Radiation Force Using an Ultrasound Transducer: A Feasibility Study. NIH. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961774/

Martínez, J. (2022, October 3). Tonometry Technology Growing in Leaps and Rebounds. The Ophthalmologist. https://theophthalmologist.com/business-profession/dr-martinez-de-la-casa-on-his-use-of-icare-rebound-tonometers

National Glaucoma Research. (2021, July 14). Glaucoma: Facts & Figures. BrightFocus. https://www.brightfocus.org/glaucoma/article/glaucoma-facts-figures

Palko, J., & Realini, T. (2023, November 5). Chapter 9 - The role of circadian and extrinsic intraocular pressure fluctuations. ScienceDirect. https://www.sciencedirect.com/science/article/pii/B9780323884426000236

Ruberto, C., Stefano, A., & Comelli, A. (2022, October 8). Using an Ultrasound Tissue Phantom Model for Hybrid Training of Deep Learning Models for Shrapnel Detection. NIH. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604600/

Salvetat, M., Zeppieri, M., Miani, F., Tosoni, C., Parisi, L., & Brusini, P. (2011, May 25). Comparison of iCare tonometer and Goldmann applanation tonometry in normal corneas and in eyes with automated lamellar and penetrating keratoplasty. NIH. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171271/

Susanna, R., Moraes, C., Cioffi, G., & Ritch, R. (2015, March 9). Why Do People (Still) Go Blind from Glaucoma? NIH. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354096/

Usgaonkar, U., Naik, R., & Shetty, A. (2023, November 5). The economic burden of glaucoma on patients. Indian Journal of Ophthalmology. https://journals.lww.com/ijo/fulltext/2023/02000/the_economic_burden_of_glaucoma_on_patients.50.aspx

Zeppieri, M., & Gurnani, B. (2023, June 11). Applanation Tonometry. NIH. https://www.ncbi.nlm.nih.gov/books/NBK582132/

Zhang, J., Zhang, Y., & Li, Y. (2017, May 31). Correlation of IOP with Corneal Acoustic Impedance in Porcine Eye Model. BioMed Research International. https://www.hindawi.com/journals/bmri/2017/2959717/

Research & Validation

Our technology is backed by rigorous scientific research and clinical validation, ensuring accuracy and reliability you can trust.

Clinical Results

Detection Accuracy92.6%
Early Detection Rate87.3%
Patient Satisfaction96.2%

Scientific Foundation

Our research is built on decades of ophthalmological science and cutting-edge AI development. We've conducted extensive clinical trials with leading medical institutions to validate our technology's effectiveness and safety.

3-year longitudinal study with 2,500+ participants
FDA breakthrough device designation
Published in 12+ peer-reviewed journals
Collaboration with 15+ medical centers

Recent Publications

AI-Powered Glaucoma Detection in Wearable Devices: A Clinical Validation Study

Journal of Medical Internet Research

2024

Continuous Intraocular Pressure Monitoring: Breakthrough in Early Glaucoma Detection

Ophthalmology Science

2024

Machine Learning Applications in Preventive Eye Care: A Systematic Review

Nature Digital Medicine

2023

Wearable Technology for Chronic Disease Management: Focus on Glaucoma

IEEE Transactions on Biomedical Engineering

2023

Contact Us

Ready to revolutionize your eye health? Get in touch with our team to learn more about GlaucoNova Labs and our innovative technology.

Get In Touch

Email

sohamchakraborty03@gmail.com

Phone

+1 (510) 320-6984

Address

123 Innovation Drive
San Francisco, CA 94105

Send us a message